AusDoc brings you the latest news from the American College of Rheumatology virtual congress 2020.

Oral methotrexate significantly improves physical function in patients who have knee osteoarthritis with inflammation, a study shows.

In a trial of 249 patients with primary radiographic-confirmed knee osteoarthritis (OA) with joint swelling and six months or more of pain, rheumatologists in Kolkata, India, compared methotrexate 15-20mg a week with a placebo substitute, glucosamine 1500mg a day.

The men and women, aged between 40 and 65 years, were divided into inflammatory (172) versus non-inflammatory (77) groups based on erythrocyte sedimentation rate and C-reactive protein measurements, ACR Convergence, the American College of Rheumatology’s virtual congress was told.